Executive Director Medical Affairs
Pubblicato il 03-10-2026 - Regeneron in Milano
Executive Director Medical Affairs - Hematology
Join to apply for the Executive Director Medical Affairs - Hematology role at Regeneron
Our Medical Affairs physicians and scientists are experts on our medicines and form an extremely valuable part of our global development organization. We serve as an important liaison between Regeneron and the scientific and healthcare community. Medical Affairs is organized in an optimally aligned matrix structure for delivery of therapeutic and functional area expertise.
As Regeneron has recently expanded with international offices, we are seeking a strong leader who is able to manage the Hematology Medical Team in these markets, to develop and execute on local medical affairs strategies to support the Hematology franchise needs in alignment with the Global Medical affairs HEM Franchise strategies, and adapted to local market needs. The role will closely partner with the HEM Global Medical Affairs Franchise Head and the global Hematology Medical Leads. Importantly,
this role will establish strong partnership with the International Commercial and Market Access Partners and contribute to accelerating the pipeline by supporting our clinical development programs. This leader will cover all markets for the Hematology franchise - direct and indirect - and will also support future pipeline assets as they emerge to address their needs across pre-launch, launch, life-cycle management, and in-market.
Ability to work with a “start-up mindset” is key as the offices are new and continuing to grow and evolve. The selected individual will work closely with the Heads of Commercial Oncology/Hematology, Market Access, and Regulatory Affairs, including other key senior leaders within the international organization.
A Typical Day Might Include
- Representing Regeneron for International markets, for Hematology Medical Affairs and Clinical Development functions, excluding the USA and Japan.
- Overseeing and evolving a newly formed international medical